What is Apremilast 30mg ?
Apremilast 30mg Tablet is used in the treatment of moderate to severe plaque psoriasis which is a type of skin condition. This medicine is used when other conventional treatments cannot be used or if the patient is not responsive or intolerant to any of these treatments.
How Apremilast 30mg Tablet is used?
Apremilast 30mg Tablet can be taken with or without food. Take it regularly and don’t stop taking the medicine even if you get better until that doctor tells you it is alright to stop. You may need to monitor your weight regularly while taking the medicine as it may cause weight loss.
Common side effects of this Tablet:
Taking this medicine may cause few common side effects such as nausea, diarrhea, and vomiting. If these side effects persist or get worse, let your doctor know. Your doctor may help with ways to reduce or prevent these symptoms by prescribing you an alternative medicine or by adjusting the dose.
To make sure the medicine is safe for you, before taking this Tablet, let your doctor know all the other medicines you are taking. If you are pregnant or breastfeeding, then consult your doctor first before taking this medicine.
Before taking it, tell your doctor if you have heart disease, liver, or kidney problems or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.
After Using this medicine, it is advised to go for regular blood tests to check the levels of calcium and phosphate in the blood. Inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding. It is not advised to consume alcohol after taking this medicine. In patients with kidney and liver disorders, dose adjustment may be required. Discussed with your doctor.
Brand Name: Apraize
Manufacturer: Ipca laboratories